risks with glp 1 Managing GLP-1 therapy side effects a Clinician Guide | Obesity Action Coalition posted on the topic GLP-1s and Eye Health: What

Additional Firms Receive FDA Warning Letters Over GLP-1 Product Sales The April 7, 2026 postings show the same enforcement action extended to multiple firms marketing unapproved GLP-1 products online

Assessment of Changes in Body Composition After 3 Months of Dulaglutide Treatment

Individuals taking the drug have reported vision loss, blurry vision, and even blindness, raising concerns over the safety of the drug

If you're taking a GLP-1 and notice symptoms such as fatigue, dizziness, or dry mouth, dehydration may be one possible cause

lights on at 07:00) and a temperature-controlled environment with food and water available ad libitum